ArticleBritish journal of clinical pharmacology2026

Maximal use of 0.05% topical isotretinoin in patients with congenital ichthyosis results in low systemic exposure.

Holm Schneider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.